Published in Drug Law Weekly, February 6th, 2007
Tests evaluating ImmuneRegen's Viprovex as a measure in the possible treatment of influenza virus infection were conducted at Virion Systems, Inc., (VSI), a Maryland biotechnology corporation. Influenza studies were performed using a cotton rat (Sigmodon hispidus) model system with the influenza A/Wuhan/359/95 (H3N2), a robust, peer-reviewed model system for studying human influenza.
Management believes preliminary results of Viprovex...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.